BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31533277)

  • 1. Medical Outcomes in Women Who Became Pregnant after Vaccination with a Virus-Like Particle Experimental Vaccine against Influenza A (H1N1) 2009 Virus Tested during 2009 Pandemic Outbreak.
    Cérbulo-Vázquez A; Arriaga-Pizano L; Cruz-Cureño G; Boscó-Gárate I; Ferat-Osorio E; Pastelin-Palacios R; Figueroa-Damian R; Castro-Eguiluz D; Mancilla-Ramirez J; Isibasi A; López-Macías C
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31533277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.
    Valero-Pacheco N; Pérez-Toledo M; Villasís-Keever MÁ; Núñez-Valencia A; Boscó-Gárate I; Lozano-Dubernard B; Lara-Puente H; Espitia C; Alpuche-Aranda C; Bonifaz LC; Arriaga-Pizano L; Pastelin-Palacios R; Isibasi A; López-Macías C
    PLoS One; 2016; 11(2):e0150146. PubMed ID: 26919288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seropositivity of influenza A H1NI in mothers and infants following maternal vaccination with trivalent seasonal influenza vaccine after the 2009 pandemic.
    Chao AS; Chang YL; Chao A; Wu TS; Yang LY; Lian R; Huang YC
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):37-40. PubMed ID: 28254223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.
    López-Macías C; Ferat-Osorio E; Tenorio-Calvo A; Isibasi A; Talavera J; Arteaga-Ruiz O; Arriaga-Pizano L; Hickman SP; Allende M; Lenhard K; Pincus S; Connolly K; Raghunandan R; Smith G; Glenn G
    Vaccine; 2011 Oct; 29(44):7826-34. PubMed ID: 21816199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy.
    Fabiani M; Bella A; Rota MC; Clagnan E; Gallo T; D'Amato M; Pezzotti P; Ferrara L; Demicheli V; Martinelli D; Prato R; Rizzo C
    Vaccine; 2015 May; 33(19):2240-2247. PubMed ID: 25820060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.
    López-Macías C
    Hum Vaccin Immunother; 2012 Mar; 8(3):411-4. PubMed ID: 22330956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of influenza A H1N1 and seroconversion of mothers and infants induced by a single dose of monovalent vaccine.
    Chao A; Huang YC; Chang YL; Wang TH; Chang SD; Wu TS; Wu TL; Chao AS
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):356-9. PubMed ID: 24075373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.
    Tsatsaris V; Capitant C; Schmitz T; Chazallon C; Bulifon S; Riethmuller D; Picone O; Poulain P; Lewin F; Lainé F; Jacqz-Aigrain E; Aboulker JP; Launay O;
    Ann Intern Med; 2011 Dec; 155(11):733-41. PubMed ID: 22147712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers.
    Conlin AMS; Bukowinski AT; Levine JA; Khodr ZG; Kaur N; Farrish SC; Sevick CJ
    Vaccine; 2018 May; 36(20):2855-2860. PubMed ID: 29625766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
    Pasternak B; Svanström H; Mølgaard-Nielsen D; Krause TG; Emborg HD; Melbye M; Hviid A
    JAMA; 2012 Jul; 308(2):165-74. PubMed ID: 22782418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study.
    Tavares F; Nazareth I; Monegal JS; Kolte I; Verstraeten T; Bauchau V
    Vaccine; 2011 Aug; 29(37):6358-65. PubMed ID: 21596080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain.
    Sammon CJ; McGrogan A; Snowball J; de Vries CS
    Hum Vaccin Immunother; 2013 Apr; 9(4):917-23. PubMed ID: 23364304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination.
    Baum U; Leino T; Gissler M; Kilpi T; Jokinen J
    Vaccine; 2015 Sep; 33(38):4850-7. PubMed ID: 26238723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.
    Helmig RB; Maimburg RD; Erikstrup C; Nielsen HS; Petersen OB; Nielsen LP; Hvidman L; Veirum JE; Henriksen TB; Storgaard M
    Acta Obstet Gynecol Scand; 2015 Aug; 94(8):833-9. PubMed ID: 25958884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study.
    Launay O; Krivine A; Charlier C; Truster V; Tsatsaris V; Lepercq J; Ville Y; Avenell C; Andrieu T; Rozenberg F; Artiguebielle F; Tréluyer JM; Goffinet F;
    PLoS One; 2012; 7(12):e52303. PubMed ID: 23300637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining responsiveness to influenza vaccination with progression of human pregnancy.
    Schlaudecker EP; Ambroggio L; McNeal MM; Finkelman FD; Way SS
    Vaccine; 2018 Jul; 36(31):4734-4741. PubMed ID: 29941326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn.
    Blanchard-Rohner G; Meier S; Bel M; Combescure C; Othenin-Girard V; Swali RA; Martinez de Tejada B; Siegrist CA
    Pediatr Infect Dis J; 2013 Dec; 32(12):1374-80. PubMed ID: 24569309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
    Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth.
    Richards JL; Hansen C; Bredfeldt C; Bednarczyk RA; Steinhoff MC; Adjaye-Gbewonyo D; Ault K; Gallagher M; Orenstein W; Davis RL; Omer SB
    Clin Infect Dis; 2013 May; 56(9):1216-22. PubMed ID: 23378281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.